Compare GAME & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GAME | SRTS |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 44.3M |
| IPO Year | 2024 | 2016 |
| Metric | GAME | SRTS |
|---|---|---|
| Price | $0.36 | $3.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 811.1K | 24.5K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,999,302.00 | $27,482,000.00 |
| Revenue This Year | $87.12 | $2.00 |
| Revenue Next Year | $21.14 | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $2.66 |
| 52 Week High | $1.24 | $5.92 |
| Indicator | GAME | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 54.06 |
| Support Level | $0.37 | $2.87 |
| Resistance Level | $0.48 | $3.17 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 52.49 | 55.56 |
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.